Menu

Speaking of Science

May 2013's selection of notable quotes

May 1, 2013
The Scientist Staff

PHOTO BY J. CAMERON/WIKIMEDIA COMMONS

At last gleams of light have come,
& I am almost convinced (quite
contrary to opinion I started with)
that species are not (it is like
confessing a murder) immutable.

—Naturalist Charles Darwin, in a letter to friend and colleague Joseph Hooker, one of many pieces of correspondence between the two biologists that were recently made available online for the first time (January 11, 1844)

This financial stress on institutions comes at a really tough time. It has a chilling effect on what was already a chilly situation.

Debra Stewart, president of the Council of Graduate Schools, discussing the effects of sequestration on enrollment in US graduate schools (April 3)

This initiative is a boost for the brain
like the Human Genome Project was
for the genes. This is the start of the
million neuron march.

Terrence Sejnowski, neuroscientist at the
Salk Institute for Biological Studies, on the recently announced Brain Research
through Advancing Innovative Neurotechnologies (BRAIN) Initiative,
to which $100 million is devoted in President Barack Obama’s 2014
budget proposal (April 2)

One of the wonderful things about transgenesisis that we can do all at once what evolution has taken million of years to do.

—Yale University geneticist Francis Ruddle, who produced the first transgenic mouse using viral DNA in 1980 and died on March 10, as quoted in his New York Times obituary (March 20)

Most of the experiments we do are irrelevant . . . . We’re not going to cure cancer by doubling the money. We’re going to do it by being more intelligent. The money thing is just a red herring of people not thinking.

— Biologist and Nobel Laureate James Watson, in remarks after a recent public lecture on the role of antioxidants in cancer at the University of California, San Diego (March 21)

You should take all elderly scientists with a grain of salt—including me.

—Biochemist and Nobel Laureate Roger Tsien, in reply to questions about a tense exchange he had with Watson at the UC San Diego lecture (March 21)

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.